Investments
AVEVA to invest c.£30million in Cambridge Research and Development hub to support future growth
Global industrial software leader to consolidate its Cambridge teams at Science Park global HQ ahead of a 2027 opening, reinforcing its long-term commitment to the city and its Industrial Intelligence strategy. ...
Daniel Zeichner MP welcomes Astrazeneca’s £300 million investment as boost for Cambridge
Daniel Zeichner, MP for Cambridge, has welcomed the announcement made by the Prime Minister, Sir Keir Starmer, during Prime Minister’s Questions today that AstraZeneca will invest £300 million into the UK’s life sciences sector. ...
12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033
This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP). ...
The Common Thread — Monthly Networking Morning
Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...
The Common Thread — Monthly Networking Morning
Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...
Book launch: 'Research Handbook on Corporate Psychopaths'
Introducing the novel theory of corporate psychopathy, the Research Handbook defines and measures the characteristics, behaviours, and impacts of psychopathic individuals from a personal to a societal scale. This unique book presents theoretical, multidisciplinary and applied research i...
Investor-Ready: Growth and Governance Series – Part 2: The Investor View
This Investor-Ready Series has been designed for founders, senior leaders, and operational teams in early-stage companies. Join legal, regulatory, forensic, behavioural, and cultural experts from Ropes & Gray and FRA who draw on their deep experience with regulatory and financial cr...
Investor-Ready: Growth and Governance Series – Part 2: The Investor View
This Investor-Ready Series has been designed for founders, senior leaders, and operational teams in early-stage companies. Join legal, regulatory, forensic, behavioural, and cultural experts from Ropes & Gray and FRA who draw on their deep experience with regulatory and financial cr...
From Innovation to Impact - POSTPONED
Due to unforeseen circumstances this event has been postponed. Registered attendees will be notified directly. Thank you for your patience and understanding. Enabling the next generation of science-driven companiesFor researchers, spin-outs and start-ups ...
PEM advises Prestige Purchasing Holdings Ltd on its acquisition by Entegra Europe UK Ltd.
PEM has advised Prestige Purchasing Holdings Limited on its acquisition by Entegra Europe UK Limited, a subsidiary of Sodexo S.A., in a transaction that strengthens Entegra’s position in the UK hospitality and procurement sector.The transaction sees Entegra Europe UK acquire 100% of Pre...